Alpha-1-antitrypsin (AAT) inhibits Mycobacterium intracellulareinduction of monocyte colony stimulating factor: another host defense function of AAT

This study demonstrates that alpha-1-antitrypsin (AAT) enhances host defense against *Mycobacterium intracellulare* by binding to the glucocorticoid receptor to differentially regulate cytokine expression, specifically inhibiting infection-induced M-CSF while promoting GM-CSF, thereby skewing macrophages toward a phenotype more effective at controlling mycobacterial burden.

The Gist

The Big Picture: A Double-Edged Sword in Your Immune System

Imagine your immune system as a highly trained security team guarding a fortress (your lungs). When a burglar (a bacteria called Mycobacterium intracellulare, or MAC for short) breaks in, the security team needs to react fast.

Usually, we think of Alpha-1-antitrypsin (AAT) as a "fire extinguisher." Its main job is to stop the security team from accidentally burning down the house by putting out their own flames (inflammation). But this study discovered a secret superpower: AAT isn't just a fire extinguisher; it's also a smart tactical commander that can reprogram the security guards to fight the burglar more effectively.

The Cast of Characters

1. MAC (The Burglar): A tough bacteria that hides inside your immune cells (macrophages) and refuses to leave.
2. AAT (The Commander): A protein in your blood that usually calms things down but, in this case, helps organize the defense.
3. The Glucocorticoid Receptor (GR): Think of this as the Command Center inside the security guard's office. It's where orders are written down.
4. GM-CSF (The "War Mode" Signal): A message that tells the guards: "Get tough! Turn into a warrior (M1) and kill the intruder!"
5. M-CSF (The "Peacekeeper" Signal): A message that tells the guards: "Calm down. We are done fighting; let's just clean up the mess and heal the damage (M2)."

The Story Unfolds

1. The Burglar Arrives

When MAC breaks into the security guard (the macrophage), it tries to take over. It sends out signals to confuse the guard.

• What happens: The burglar actually tricks the guard into sending out both the "War Mode" signal (GM-CSF) and the "Peacekeeper" signal (M-CSF).
• The Problem: If the guard listens too much to the "Peacekeeper" signal, they become too soft to kill the bacteria. They become "M2" macrophages, which are great at healing wounds but terrible at killing intruders.

2. The Commander Arrives (AAT)

This is where AAT steps in. The researchers found that AAT goes into the guard's office, sits at the Command Center (GR), and rewrites the orders.

• The Smart Move: AAT tells the guard: "Keep the 'War Mode' signal (GM-CSF) loud and clear!" This keeps the guard in "M1" warrior mode, ready to kill the bacteria.
• The Block: AAT also says, "Stop the 'Peacekeeper' signal (M-CSF)!" It blocks the message that would make the guard lazy and friendly toward the bacteria.

The Analogy: Imagine a noisy party (the infection). The burglar is trying to get everyone to stop dancing and start napping (M2/Peacekeeper). AAT comes in, turns up the music (GM-CSF/Warrior), and puts a mute button on the "Nap Time" announcement (M-CSF). The result? The guards stay awake, energetic, and ready to fight.

3. The Secret Weapon: The Command Center

The researchers did something clever: they removed the Command Center (GR) from some of the guards to see what happened.

• Without the Command Center: When AAT tried to give orders, the guards didn't listen. The "Peacekeeper" signal (M-CSF) kept coming through, and the guards didn't get as good at killing the bacteria.
• The Discovery: This proved that AAT needs to talk to the Command Center (GR) to successfully stop the "Peacekeeper" signal. It's like AAT needs the keys to the office to change the shift schedule.

4. The Twist: Protein vs. Instructions

There was one surprise. AAT stopped the instructions (mRNA) for the "Peacekeeper" signal using the Command Center. But when they looked at the actual messengers (proteins) floating around, AAT stopped them even if the Command Center was missing!

• What this means: AAT has a "Plan B." It can stop the peace signals even without the main office, perhaps by intercepting the messengers on their way out the door.

Why Does This Matter?

The study concludes that AAT helps your body fight this specific bacteria by doing two things at once:

1. Boosting the Warriors: It keeps the "kill the bacteria" signal (GM-CSF) active.
2. Silencing the Peacemakers: It stops the "let's be nice" signal (M-CSF) that would let the bacteria hide.

The Timeline Analogy:

• Early Infection: You need AAT to be high. It keeps the "War Mode" (GM-CSF) high and the "Peace Mode" (M-CSF) low so the bacteria get killed quickly.
• Late Infection (Healing): Once the bacteria are dead, you want AAT to go back to normal levels. This allows the "Peace Mode" (M-CSF) to return, helping the lung tissue heal and stop the inflammation from damaging the house.

The Bottom Line

This paper shows that Alpha-1-antitrypsin isn't just a passive protector; it's an active strategist. It manipulates the immune system's "volume knobs" to ensure the right amount of aggression is used to kill bacteria, without letting the bacteria trick the immune system into becoming too friendly. This could lead to new treatments for people who struggle with these stubborn lung infections.

Technical Summary

1. Problem Statement

Non-tuberculous mycobacteria (NTM), specifically the Mycobacterium avium complex (MAC), cause chronic lung diseases with increasing prevalence and mortality, partly due to intrinsic drug resistance. While Alpha-1-antitrypsin (AAT) is known for its serine protease inhibitory function, it also possesses host-defense properties independent of this mechanism. Previous studies established that AAT binds to the cytoplasmic glucocorticoid receptor (GR) to regulate gene expression, enhancing macrophage killing of mycobacteria. However, the specific transcriptional and post-transcriptional mechanisms by which the AAT-GR complex modulates macrophage responses during active MAC infection, particularly regarding the balance between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes, remained unclear.

2. Methodology

The study utilized a combination of bulk RNA sequencing (RNA-seq), quantitative PCR (RT-qPCR), ELISA, and bacterial burden quantification in a human monocytic cell line model.

• Cell Model: Differentiated THP-1 macrophages were used. Two groups were established:
  • THP-1control: Cells infected with a scrambled shRNA.
  • THP-1GR-KD: Cells stably knocked down for the Glucocorticoid Receptor (GR) using shRNA-lentivirus.
• Experimental Conditions: Four groups were analyzed:
  1. Control (uninfected, no AAT).
  2. MAC-infected (M. intracellulare, MOI 10:1).
  3. MAC-infected + AAT (3 mg/mL).
  4. MAC-infected + AAT + GR-KD.
• Omics Analysis: RNA was extracted at 48 hours post-infection. Bulk RNA-seq was performed (Illumina NovaSeq 6000). Data were aligned to hg38, and differential expression was analyzed using Cuffdiff. Genes with $\ge$2-fold change were considered significant. Gene Ontology (GO) enrichment was performed using DAVID.
• Validation:
  • RT-qPCR: Validated mRNA levels of CSF1 (M-CSF) and CSF2 (GM-CSF).
  • ELISA: Quantified M-CSF protein levels in supernatants.
  • Functional Assay: Macrophages were infected with MAC, treated with AAT, and co-treated with neutralizing anti-GM-CSF antibodies. Cell-associated bacterial loads were quantified via CFU counts on 7H10 agar at 1, 2, and 4 days.

3. Key Contributions

• Discovery of Dual Regulation: The study elucidates that AAT differentially regulates the expression of two critical colony-stimulating factors: it inhibits MAC-induced M-CSF (promoting M2 phenotype) while preserving or inducing GM-CSF (promoting M1 phenotype).
• Mechanistic Insight into GR Dependence: The paper distinguishes between transcriptional and post-transcriptional regulation. It demonstrates that AAT's inhibition of CSF1 mRNA is GR-dependent, whereas the inhibition of M-CSF protein secretion involves GR-independent mechanisms.
• Functional Validation: The study proves that the host-protective effect of AAT (reduction of bacterial burden) is partially mediated by endogenous GM-CSF, as neutralizing GM-CSF abrogates AAT's ability to reduce MAC burden.

4. Key Results

A. Global Transcriptional Changes

• MAC Infection: Induced 1,977 genes and downregulated 2,303 genes in control cells. Upregulated genes included IL23A, IL1B, CSF2 (GM-CSF), and CSF1 (M-CSF). Downregulated genes included CX3CR1 and various Matrix Metalloproteinases (MMPs).
• AAT Effect in MAC-infected Cells: AAT upregulated 1,200 genes and downregulated 890 genes. Notably, AAT significantly downregulated CSF1 (M-CSF) mRNA but did not inhibit CSF2 (GM-CSF) mRNA induction caused by MAC.

B. The Role of the Glucocorticoid Receptor (GR)

• GR-Dependent Regulation: The regulation of 1,683 genes by AAT+MAC was attenuated in GR-KD cells, indicating these genes require GR for AAT-mediated regulation. This group included HLA-DQB1, IL-23A, TLR2, and IL1B.
• GR-Attenuated Regulation: The regulation of 1,624 genes was augmented in GR-KD cells, suggesting GR normally suppresses these genes in the presence of AAT+MAC. This group included NOS2, IL-12A, CCL2, and CSF1.
• Specific Finding on CSF1:
  • mRNA: AAT significantly reduced MAC-induced CSF1 mRNA in control cells. This reduction was lost in GR-KD cells, confirming GR-dependent transcriptional inhibition.
  • Protein: AAT reduced M-CSF protein levels in both control and GR-KD cells. This indicates that AAT inhibits M-CSF protein via a GR-independent mechanism (likely post-transcriptional).

C. Functional Impact of GM-CSF

• Bacterial Burden: AAT treatment reduced cell-associated MAC burden by ~50% at day 4.
• Neutralization: When endogenous GM-CSF was neutralized with an antibody, the ability of AAT to reduce MAC burden was significantly abrogated. This confirms that AAT-induced GM-CSF is a critical effector of host defense against MAC.

5. Significance and Conclusion

The study proposes a novel host-defense mechanism where AAT acts as a "phenotype skewer" during NTM infection:

1. Early Infection Phase: AAT induces GM-CSF (via GR) and inhibits M-CSF (via GR-dependent mRNA suppression and GR-independent protein suppression). This skews macrophages toward the M1 phenotype (pro-inflammatory, pathogen-killing), enhancing the clearance of MAC.
2. Resolution Phase: The authors hypothesize that as AAT levels normalize, the inhibition of M-CSF lifts, allowing a shift toward the M2 phenotype (anti-inflammatory, tissue repair) to prevent excessive tissue damage.

Clinical Implications:

• These findings suggest that AAT therapy could be a viable host-directed treatment for NTM lung disease, not just by inhibiting proteases, but by modulating the macrophage cytokine profile to favor bacterial killing.
• The differential regulation of M-CSF and GM-CSF highlights the complexity of the AAT-GR axis and suggests that therapeutic strategies might need to target specific downstream effectors (like GM-CSF) to maximize efficacy.

Limitations:
The study relies on the THP-1 cell line. While the authors argue this allows for stable GR knockdown and mimics primary macrophage responses, genotypic differences in primary human cells could alter these regulatory dynamics.